Rehabilitation Robot in Patients With Post-Coronavirus Disease (COVID-19) Fatigue Syndrome

November 19, 2021 updated by: Poznan University of Medical Sciences

The Use of a Rehabilitation Robot in Patients With Post-COVID-19 Fatigue Syndrome

The aim of the study is to compare the effectiveness of two models of rehabilitation:

  • traditional neurological rehabilitation, and
  • neurological rehabilitation combined with a rehabilitation robot (Luna by EGZOTech).

An additional goal is to test the qualitative diagnostic reference using the surface electromyogram of the Luna robot (certified as a Medical Device) for functional diagnostics based on standardized clinical tests.

Study Overview

Status

Recruiting

Intervention / Treatment

Study Type

Interventional

Enrollment (Anticipated)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Poznań, Poland, 60-781
        • Recruiting
        • Poznan University of Medical Sciences
        • Contact:
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

- patients discharged from Intensive Care Units after undergone ventilator therapy due to COVID-19

Exclusion Criteria:

  • active medical condition (infections; tumors; rheumatological, metabolic, endocrine, autoimmunological, cardiovascular diseases)
  • bipolar disorder
  • dementia
  • nutritional disorders
  • addiction to alcohol or psychoactive substances
  • severe obesity
  • overtraining

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Robot
Patients treated using a rehabilitation robot
Effectiveness of using a rehabilitation robot in post-COVID-19 rehabilitation
Active Comparator: Control
Patients receiving traditional rehabilitation treatment (robot used only as assessment tool)
Effectiveness of using a rehabilitation robot in post-COVID-19 rehabilitation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in muscle fatigue assessment
Time Frame: Baseline, after 3 and after 8 weeks
Raw robot measurement data (isometric contraction of the muscle for 60 s - biceps, quadriceps)
Baseline, after 3 and after 8 weeks
Change in isokinetic muscle force
Time Frame: Baseline, after 3 and after 8 weeks
Raw robot measurement data (5 repetitions during measurement with LUNA)
Baseline, after 3 and after 8 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in functional physical ability 1
Time Frame: Baseline, after 3 and after 8 weeks
Functional Independence Measure
Baseline, after 3 and after 8 weeks
Change in functional physical ability 2
Time Frame: Baseline, after 3 and after 8 weeks
Barthel Index
Baseline, after 3 and after 8 weeks
Change in functional physical ability 3
Time Frame: Baseline, after 3 and after 8 weeks
Berg Balance Test
Baseline, after 3 and after 8 weeks
Change in functional physical ability 4
Time Frame: Baseline, after 3 and after 8 weeks
Short Physical Performance Battery
Baseline, after 3 and after 8 weeks
Change in cognitive ability 1
Time Frame: Baseline, after 3 and after 8 weeks
Addenbrooke's Cognitive Examination (ACE-III)
Baseline, after 3 and after 8 weeks
Change in cognitive ability 2
Time Frame: Baseline, after 3 and after 8 weeks
Montreal Cognitive Assessment
Baseline, after 3 and after 8 weeks
Change in the quality of life
Time Frame: Baseline, after 3 and after 8 weeks
WHOQOL
Baseline, after 3 and after 8 weeks
Change in depressive symptoms
Time Frame: Baseline, after 3 and after 8 weeks
Beck's Depression Inventory
Baseline, after 3 and after 8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Katarzyna Hojan, MD, PhD, Poznan University of Medical Sciences

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2021

Primary Completion (Anticipated)

July 31, 2022

Study Completion (Anticipated)

December 31, 2022

Study Registration Dates

First Submitted

September 3, 2021

First Submitted That Met QC Criteria

November 19, 2021

First Posted (Actual)

November 23, 2021

Study Record Updates

Last Update Posted (Actual)

November 23, 2021

Last Update Submitted That Met QC Criteria

November 19, 2021

Last Verified

November 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Post-Viral Fatigue Syndrome

Clinical Trials on Robot rehabilitation

3
Subscribe